CBNPC CANCER

Clinical trials for CBNPC CANCER explained in plain language.

Never miss a new study

Get alerted when new CBNPC CANCER trials appear

Sign up with your email to follow new studies for CBNPC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Trial halted: Two-Drug combo tested for tough lung cancers

Disease control Terminated

This study aimed to see if adding a new drug (tiragolumab) to an existing immunotherapy (atezolizumab) could better control advanced lung cancer in patients with a specific tumor feature. It planned to test this in two groups: patients new to treatment and those whose cancer had …

Matched conditions: CBNPC CANCER

Phase: PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control

Last updated Apr 04, 2026 05:20 UTC

CBNPC CANCER

Get alerted when new CBNPC CANCER trials appear

Trial halted: Two-Drug combo tested for tough lung cancers